| Hospital admissions 2000–2014: A retrospective analysis of 288 096 events in patients with dementia C Bernardes, J Massano, A Freitas Archives of gerontology and geriatrics 77, 150-157, 2018 | 64 | 2018 |
| Reconsidering the role of blood-brain barrier in Alzheimer’s disease: From delivery to target JA Sousa, C Bernardes, S Bernardo-Castro, M Lino, I Albino, L Ferreira, ... Frontiers in aging neuroscience 15, 1102809, 2023 | 27 | 2023 |
| Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia A Silva‐Spínola, M Lima, MJ Leitão, C Bernardes, J Durães, D Duro, ... European journal of neurology 30 (6), 1565-1573, 2023 | 18 | 2023 |
| Prevalence, incidence, and mortality of Multiple Sclerosis in Coimbra, Portugal I Correia, C Cunha, C Bernardes, C Nunes, C Macário, L Sousa, S Batista Neuroepidemiology 58 (1), 57-63, 2024 | 6 | 2024 |
| Montreal cognitive assessment in mild cognitive impairment: relationship with cerebrospinal fluid biomarkers and conversion to dementia C Bernardes, M Lima, D Duro, A Silva-Spínola, J Durães, ... Journal of Alzheimer's Disease 96 (3), 1173-1182, 2023 | 3 | 2023 |
| SQSTM1 Pro392Leu presenting as a corticobasal syndrome with progressive nonfluent aphasia M Tábuas-Pereira, M Lima, C Bernardes, J Durães, D Duro, I Baldeiras, ... Parkinsonism & Related Disorders 123, 106069, 2024 | 1 | 2024 |
| Natalizumab extended interval dosing: what about wearing-off effect? C Bernardes, C Fernandes, C Cunha, C Nunes, C Macário, L Sousa, ... Journal of the Neurological Sciences 458, 122930, 2024 | 1 | 2024 |
| Congenital muscular dystrophy type 1A: The role of multidisciplinary rehabilitation RM Sousa, C Bernardes, G Pires, C Vieira, I Cunha Sinapse 22 (3), 137-140, 2022 | 1 | 2022 |
| Posterior reversible encephalopathy syndrome following Miller-Fisher syndrome C Bernardes, C Silva, G Santo, I Correia BMJ Case Reports CP 14 (7), e242231, 2021 | 1 | 2021 |
| Clinical Reasoning: A 35-Year-Old Woman With Personality Change and Gait Impairment C Bernardes, JM Lemos, GC Santo Neurology 104 (2), e210252, 2025 | | 2025 |
| Exploring first-degree family history in a cohort of Portuguese Alzheimer’s disease patients: population evidence for X-chromosome linked and recessive inheritance of risk factors M Tábuas-Pereira, C Bernardes, J Durães, M Lima, AR Nogueira, ... Journal of Neurology 271 (10), 6983-6990, 2024 | | 2024 |
| Picturing the Multiple Sclerosis Patient Journey: A Symptomatic Overview I Correia, C Bernardes, C Cunha, C Nunes, C Macário, L Sousa, S Batista Journal of Clinical Medicine 13 (19), 5687, 2024 | | 2024 |
| Impact of the First Year of the COVID-19 Pandemic on Telestroke Network Performance: The Experience of a Portuguese “Drip-and-Ship” Model IV Carvalho, FM Barros, CS Fernandes, J Sousa, AI Rodrigues, ... Sinapse 24 (2), 71-77, 2024 | | 2024 |
| Predicting progression of Mild Cognitive Impairment patients through four distinctive groups obtained by a dimensionality reduction algorithm A Silva‐Spínola, MJ Leitão, M Lima, C Bernardes, D Duro, P Regueira, ... Alzheimer's & Dementia 19, e073665, 2023 | | 2023 |
| Clinical Reasoning: A 24-Year-Old Pregnant Woman With Headache and Behavioral Change Progressing to Coma C Bernardes, R Pires, C Farinha, J Lemos, C Lima, S Batista Neurology 101 (22), e2331-e2337, 2023 | | 2023 |
| Natalizumab extended interval dosing: what about wearing-off effect? C Bernardes, C Fernandes, C Cunha, S Batista, C Nunes, MC Macario, ... MULTIPLE SCLEROSIS JOURNAL 29, 1010-1011, 2023 | | 2023 |
| Switching From Natalizumab To Immune Reconstitution Therapies In Patients With Multiple Sclerosis S Matos, C Cunha, C Bernardes, J Cardoso, I Campelo, J Feio, S Batista, ... MULTIPLE SCLEROSIS JOURNAL 29, 931-931, 2023 | | 2023 |
| Neurology Publish Ahead of Print MD Catarina Bernardes, MD Ricardo Pires, C Bernardes, R Pires, ... | | 2023 |
| Development of seizures reduces survival in patients with Alzheimer's Disease C Bernardes, P Faustino, J Duraes, M Lima, D Duro, A Silva-Spinola, ... EUROPEAN JOURNAL OF NEUROLOGY 29, 375-375, 2022 | | 2022 |
| One year of natalizumab extended interval dosing: what have we learned C Bernardes, C Fernandes, I Correia, C Nunes, C Macario, S Batista, ... MULTIPLE SCLEROSIS JOURNAL 27 (2_ SUPPL), 652-652, 2021 | | 2021 |
